GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kohjin Bio Co Ltd (TSE:177A) » Definitions » Equity-to-Asset

Kohjin Bio Co (TSE:177A) Equity-to-Asset : 0.00 (As of Jun. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Kohjin Bio Co Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Kohjin Bio Co's Total Stockholders Equity for the quarter that ended in Jun. 2024 was 円0 Mil. Kohjin Bio Co's Total Assets for the quarter that ended in Jun. 2024 was 円0 Mil.

The historical rank and industry rank for Kohjin Bio Co's Equity-to-Asset or its related term are showing as below:

TSE:177A' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.4   Med: 0.5   Max: 0.62
Current: 0.62

During the past 3 years, the highest Equity to Asset Ratio of Kohjin Bio Co was 0.62. The lowest was 0.40. And the median was 0.50.

TSE:177A's Equity-to-Asset is ranked worse than
55% of 1509 companies
in the Biotechnology industry
Industry Median: 0.67 vs TSE:177A: 0.62

Kohjin Bio Co Equity-to-Asset Historical Data

The historical data trend for Kohjin Bio Co's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kohjin Bio Co Equity-to-Asset Chart

Kohjin Bio Co Annual Data
Trend Mar22 Mar23 Mar24
Equity-to-Asset
0.40 0.49 0.51

Kohjin Bio Co Quarterly Data
Mar22 Mar23 Dec23 Mar24 Jun24 Sep24
Equity-to-Asset Get a 7-Day Free Trial 0.49 0.50 0.51 - 0.62

Competitive Comparison of Kohjin Bio Co's Equity-to-Asset

For the Biotechnology subindustry, Kohjin Bio Co's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kohjin Bio Co's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Kohjin Bio Co's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Kohjin Bio Co's Equity-to-Asset falls into.



Kohjin Bio Co Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Kohjin Bio Co's Equity to Asset Ratio for the fiscal year that ended in Mar. 2024 is calculated as

Equity to Asset (A: Mar. 2024 )=Total Stockholders Equity/Total Assets
=3342.392/6589.322
=0.51

Kohjin Bio Co's Equity to Asset Ratio for the quarter that ended in Jun. 2024 is calculated as

Equity to Asset (Q: Jun. 2024 )=Total Stockholders Equity/Total Assets
=0/0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kohjin Bio Co  (TSE:177A) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Kohjin Bio Co Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Kohjin Bio Co's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Kohjin Bio Co Business Description

Traded in Other Exchanges
N/A
Address
5-1-3 Chiyoda, Sakado, Saitama, JPN, 350-0214
Kohjin Bio Co Ltd is engaged in development, manufacture and sale of culture media (growing environments used for culturing microorganisms and cells) and contract manufacturing of processed cell products. It has manufacturing and sales of animal blood, sera, tissue culture media, media for microbiology testing, in vitro diagnostic agents, and cosmetics.

Kohjin Bio Co Headlines

No Headlines